Keywords: positive, ibs, data, salix, xifaxan, usa, pharmaceuticals

Positive IBS data for Salix' Xifaxan

Article | 29 May 2006

Print This

The USA's Salix Pharmaceuticals has presented strong data on its drug candidate Xifaxan (rifaximin) at the Digestive Disease Week annual ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in